CAR-T, namely chimeric antigen receptor T cell immunotherapy. Simply speaking, CAR-T is to transform the patient's immune T cells in vitro through biotechnology to make them recognize the antigens on the surface of tumor cells, and then put these cells back into the patient to achieve the therapeutic effect of identifying and killing cancer cells.
